Skip to main content

Kodiak Sciences Inc.

For the period ended Dec 31, 2025. Filed Mar 31, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 31, 2026

KOD$108.06+0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 15. Exhibits and Financial Statement Schedules

(a) The following documents are filed as part of this Annual Report on Form 10-K:

(1) FINANCIAL STATEMENTS

The consolidated financial statements are filed as part of this Annual Report on Form 10-K under Item 8.

(2) FINANCIAL STATEMENT SCHEDULES

All schedules to the consolidated financial statements are omitted as the required information is either inapplicable or presented in the consolidated financial statements.

(3) EXHIBITS

EXHIBIT INDEX

Exhibit · Incorporated by Reference
NumberDescriptionFormFile No.ExhibitFiling Date
3.1Amended and Restated Certificate of Incorporation of Kodiak Sciences Inc.10-Q001-386823.111/16/2018
3.2Amended and Restated Bylaws of Kodiak Sciences Inc.10-Q001-386823.211/16/2018
4.1Form of Common Stock CertificateS-1/A333-2272374.19/24/2018
4.2Investors’ Rights Agreement, dated September 8, 2015, as amended, by and among the registrant and the investors and founders named thereinS-1/A333-2272374.29/24/2018
4.3Description of Securities10-K001-386824.63/16/2020
4.4Registration Rights Agreement, dated March 1, 2021, by and among the registrant and the investors named therein10-K001-386824.73/1/2021
10.1+Form of Director and Officer Indemnification AgreementS-1/A333-22723710.19/24/2018
10.2+2009 Options and Profits Interest PlanS-1333-22723710.29/7/2018
10.3+2015 Share Incentive PlanS-1333-22723710.39/7/2018
10.4+Form of Notice of Stock Option Grant and Stock Option Agreement under the 2009 Option and Profits Interest PlanS-1333-22723710.49/7/2018
10.5+Form of Notice of Stock Option Grant and Stock Option Agreement under the 2015 Share Incentive PlanS-1333-22723710.59/7/2018
10.6+2018 Equity Incentive PlanS-1/A333-22723710.69/24/2018
10.7+Form of Notice of Stock Option Grant and Stock Option Agreement under the 2018 Equity Incentive PlanS-1/A333-22723710.79/24/2018
10.8+Form of Notice of Restricted Stock Unit Grant and Terms and Conditions of Restricted Stock Unit Grant under the 2018 Equity Incentive PlanS-1/A333-22723710.89/24/2018
10.9+2018 Employee Stock Purchase PlanS-1/A333-22723710.99/24/2018
Exhibit · Incorporated by Reference
NumberDescriptionFormFile No.ExhibitFiling Date
10.10+Form of Subscription Agreement under the 2018 Employee Stock Purchase PlanS-1/A333-22723710.109/24/2018
10.11+Executive Employment Agreement, effective as of September 6, 2018, between the Registrant and Victor PerlrothS-1/A333-22723710.119/24/2018
10.12+Amended Executive Employment Agreement, effective as of September 6, 2018, between the Registrant and John BorgesonS-1/A333-22723710.129/24/2018
10.13+Executive Incentive Compensation PlanS-1/A333-22723710.159/24/2018
10.14Funding Agreement, dated as of December 1, 2019, between Kodiak Sciences Inc., Kodiak Sciences GmbH and Baker Bros. Advisors, LP8-K001-3868210.112/2/2019
10.15Lease Agreement for 1200 Page Mill Road, Building 3, by and between the Registrant and 1050 Page Mill Road Property, LLC, dated June 19, 202010-Q001-3868210.18/10/2020
10.16Lease Agreement for 1250 Page Mill Road, Building 4, by and between the Registrant and 1050 Page Mill Road Property, LLC, dated June 19, 202010-Q001-3868210.28/10/2020
10.17Letter Agreement, dated July 22, 20218-K001-3868210.17/23/2021
10.182021 Long-Term Performance Incentive Plan10-Q001-3868210.111/9/2021
10.19Underwriting Agreement, dated as of December 16, 2025, by and among Kodiak Sciences Inc., J.P. Morgan Securities LLC, Jefferies LLC, Evercore Group L.L.C. and UBS Securities LLC.8-K001-386821.112/18/2025
19.1Kodiak Sciences Inc. Insider Trading Policy10-K001-3868219.13/27/2025
21.1*Subsidiaries of the Company
23.1*Consent of Independent Registered Public Accounting Firm
24.1*Power of Attorney (included in signature page)
31.1*Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit · Incorporated by Reference
NumberDescriptionFormFile No.ExhibitFiling Date
31.2* · Certification of Principal Financial and Accounting Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1* · Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2* · Certification of Principal Financial and Accounting Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
97.1Incentive Compensation Recoupment Policy10-K001-3868297.13/28/2024
101.INSInline XBRL Instance Document
101.SCHInline XBRL Taxonomy Extension Schema With Embedded Linkbases Document
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
  • Filed herewith.
  • Indicates management contract or compensatory plan.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.